As India’s dermatology and dermo-cosmetic market moves increasingly towards evidence-based and science-backed skincare, global dermatology company Sesderma is stepping up its presence in the country.
This, with greater engagement with the dermatology community and continued investments in research and innovation tailored to Indian skin.
Founded by renowned dermatologist Gabriel Serrano, Sesderma has built its global reputation around research-driven dermatological solutions.
As part of its India expansion, Sesderma will host exclusive and interactive knowledge-exchange conventions, titled ‘Grand Dermatology Symposiums’, featuring Gabriel Serrano. The symposiums will focus on some of the latest developments in regenerative dermatology, nanotechnology-based dermo-cosmetics, micro-needling technologies, skin longevity, healthy skin ageing and chemical peels tailored to Indian skin photo types.
Speaking on his upcoming visit to India, Serrano says, “I have always been committed to innovation and research, and I firmly believe that continuing to develop effective products and treatments is the only way to deliver the best. India’s dynamic skin profiles with growing demand for science-backed skincare makes for an exciting chapter ahead."
Iberia Pharmaceuticals, the official and exclusive partner for Sesderma in India, is playing a key role in driving the brand’s growth across the country. With its established presence in the dermatology ecosystem, deep market knowledge and nationwide distribution capabilities, Iberia is spearheading Sesderma’s expansion into emerging markets, including Tier-II cities.
Highlighting the partnership, Nitin Jain, Founder and Managing Director, Iberia Pharmaceuticals, says, “The Indian youth is increasingly seeking skin care products backed by science-based formulations, and we at Iberia firmly believe that bringing world-class skincare solutions to India is key to this new wave of demand. Our partnership with Sesderma is built on a shared commitment to scientific excellence, innovation, and delivering advanced derma-tech in India.”
Commenting on the symposiums Saurav Ojha, Co-Founder & Whole-Time Director at Iberia Pharmaceuticals says “At Iberia Pharmaceuticals, our aim has primarily been to bring the best of global dermatological science-backed skincare to India that addresses the unique needs of the Indian skin. The symposiums hosted by us for the celebrated Gabriel Serrano provides a powerful knowledge exchange platform to India’s dermatological community.”
With demand for science-backed skincare and clinically certified dermo-cosmetic solutions continuing to rise, Sesderma and Iberia Pharmaceuticals are looking beyond India’s metropolitan markets. The companies are expanding their footprint into Tier-II cities, with a focus on making advanced dermatological skincare innovations more accessible to consumers nationwide.
